Procter & Gamble Health Share Price

₹ 5,870.00

+₹61.00 (1.05%)
1D
Last updated 13 Nov, 2026, 15:29 IST
NSE: PGHL
|
Pharmaceuticals

Procter & Gamble Health Share Price Today

As of 15 Nov 2026, Procter & Gamble Health share price is ₹5,870.00. The stock opened at ₹5,843.00, compared to its previous close of ₹5,809.00. During today's trading session, Procter & Gamble Health share price moved in the range of ₹5,717.50 to ₹5,870.00, with an average price of ₹5,793.75 for the day. Looking at its last 52-week, the stock has touched a low of ₹4,707.00 and a high of ₹6,975.00. On the performance front, Procter & Gamble Health share price has increased by 11.28% over the last six months and is down 0.78% on a year-on-year basis.

Share price over the last 1 day rose from 5835.50 to 5870.00, ranging between 5718.50 and 5870.00.
₹5,717.50
1.05% up today
₹5,870.00
1D LOW
1D HIGH

Procter & Gamble Health Stock Insights

Stock Performance
OutperformingBeat Nifty by 4.22 % in last 6 month
Shareholding Pattern
DIIDII increased stake by 10.42%
Shareholding Pattern
FIIFII increased stake by 1.49%
Procter & Gamble Health stock performance
Open₹5,843.00
High₹5,870.00
Low₹5,717.50
Prev. close₹5,809.00
Procter & Gamble Health trading activity
Volume15,547
Average traded price₹5,768.85
Last traded time03:29:49 13 Nov
Last traded quantity1
Circuit
L
H
₹4,647.50
₹6,970.50
52-week
L
H
₹4,707.00
₹6,975.00
Mkt Cap Cr
9,666.98
P/E
25.45
P/B
14.69
ROA
37.44%
ROE
57.72%
ROCE
78.25%
Quick Ratio
1.65
EV/EBITDA
17.07

Based on fundamentals, this stock's

Performance: 5 out of 5, Excellent
Performance
Excellent
P & G Health Ltd outperforming all market indices
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
P & G Health Ltd appears overvalued compared to its peers
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,51,290.9141.085.059.61%13.79%18.65%2.3123.67
Divis Laboratories3,05,014.1190.716.9515.31%18.69%23.83%3.560.87
Torrent Pharmaceuticals1,77,333.2084.499.654.7%11.42%11.37%0.7533.99
Laurus Labs1,30,755.5698.1321.5711.58%22.11%20.91%0.6855.18
Zydus Lifesciences1,20,249.0927.614.277.63%15.1%14.86%0.9116.1
Dr. Reddy's Laboratories1,15,016.8941.682.964.79%7.21%8.58%1.3519.53
Cipla1,12,538.8139.443.186.6%8.18%10.8%2.521.48
Mankind Pharma1,09,622.1748.436.237.82%12.76%14.68%0.7426.42
Aurobindo Pharma1,05,236.6226.42.676.46%10.13%12.76%1.1512.54
Lupin90,544.0117.343.7613.08%21.65%24.54%1.4210.32

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Procter & Gamble Health Company Background

ISIN
INE199A01012
Sector Market Cap
₹ 9,666.98 Cr

Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.

Procter & Gamble Health Financial Highlights

  • Revenue: Procter & Gamble Health reported revenue of ₹1,425.31 crore in FY26 vs ₹944.52 crore in FY25. It showed an increase of 50.90% on a yearly basis.
  • Operating Profit: Procter & Gamble Health reported an operating profit of ₹449.86 crore in FY26 vs ₹311.62 crore in FY25. It showed an increase of 44.36% on a year-on-year basis.
  • Net Profit: Procter & Gamble Health reported a net profit of ₹326.91 crore in FY26 vs ₹234.41 crore in FY25. It showed an increase of 39.46% on a yearly basis.

Procter & Gamble Health Quarterly Result Highlights

  • Procter & Gamble Health reported revenue of ₹386.38 crore in Sep 2026, compared with ₹367.59 crore in Jun 2026, representing an increase of 5.11% on a quarter-on-quarter (QoQ) basis.
  • Procter & Gamble Health reported an operating profit of ₹150.05 crore in Sep 2026, compared with ₹129.12 crore in Jun 2026, representing an increase of 16.21% on a quarter-on-quarter (QoQ) basis.
  • Procter & Gamble Health reported a profit of ₹111.51 crore in Sep 2026, compared with ₹96.15 crore in Jun 2026, reflecting an increase of 15.98% on a QoQ basis.
  • The earnings per share (EPS) of Procter & Gamble Health stood at ₹141.00 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
51.82%
FII
6.42%
Other DII
3.74%
Retail and other
29.13%
Mutual funds
8.89%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20256.97%
Mar 20266.20%
Jun 20266.33%
Sep 20266.42%

Procter & Gamble Health Investment Returns

1 day
--
1 week
+4.55%
1 month
+9.70%
1 year
-0.78%
3 years
+13.96%
5 years
+12.47%

Procter & Gamble Health Share Price History

Procter & Gamble Health share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
13 Nov 26
₹5,843.00 / ₹5,809.00
0.00%
12 Nov 26
₹5,800.00 / ₹5,809.00
+0.55%
11 Nov 26
₹5,699.50 / ₹5,777.50
+1.37%
09 Nov 26
₹5,716.50 / ₹5,699.50
-0.30%
Show more

Procter & Gamble Health Financials

Full statement

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Jun 2024Jun 2023Jun 2022
Revenue₹934.17₹1,151.26₹1,229.62₹1,114.41
Other Income₹10.35₹15.63₹18.39₹13.19
Total Revenue₹944.52₹1,166.89₹1,248.01₹1,127.60
Total Expenses₹632.90₹873.38₹933.81₹874.23
Profit Before Tax₹311.62₹273.32₹314.20₹253.37
Tax₹77.21₹72.34₹84.73₹60.85
Profit After Tax₹234.41₹200.98₹229.47₹192.52
EPS - Basic₹141.00₹121.00₹138.00₹116.00
EPS - Diluted₹141.00₹121.00₹138.00₹116.00

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Jun 2024Jun 2023
Profit before tax₹449.86₹311.62₹273.32₹314.20
Income before WC changes₹465.04₹323.82₹325.59₹355.69
Change in Assets-₹73.84-₹69.92₹70.57-₹97.15
Change in Liabilities₹50.44-₹3.89-₹82.68₹67.13
Change in WC-₹23.40-₹73.81-₹12.11-₹30.02
Cash flow from Operations₹337.79₹168.69₹228.29₹236.01
Cash flow from Investing₹1.26₹9.59-₹6.87-₹21.50
Cash flow from Financing-₹343.92-₹234.74-₹418.11-₹98.49
Total Cash Flow-₹4.87-₹56.46-₹196.69₹116.02
Cash (Start of the year)₹182.27₹238.73₹435.42₹319.40
Cash (End of the year)₹177.40₹182.27₹238.73₹435.42

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Jun 2024Jun 2023Jun 2022
Non-Current Assets₹267.81₹270.14₹305.09₹280.08
Current Assets₹526.39₹524.22₹796.10₹608.04
Total Assets₹794.20₹794.36₹1,101.19₹888.12
Current Liabilities₹215.31₹218.91₹303.90₹231.90
Net Current Asset₹311.08₹305.31₹492.20₹376.14
Non-Current Liabilities₹41.93₹37.21₹46.40₹39.73
Equity Capital₹536.96₹538.24₹750.89₹616.49
Total Equity & Liabilities₹794.20₹794.36₹1,101.19₹888.12
* All values are in INR Crore
Procter & Gamble Health market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
Procter & Gamble Health technical summary
Bearish indicators1
Neutral indicators6
Bullish indicators1
OverallNeutral
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict
RSI (14)
61.79
Neutral
ATR (14)
237.96
Neutral
STOCH(9,6)
63.04
Neutral
STOCH RSI (14)
57.52
Neutral
ADX(9)
42.16
Bearish
UO(9)
57.14
Neutral
ROC(12)
7.59
Bullish
WillR(14)
-22.9
Neutral
Period
Simple value
Exponential vaue
5D
5762.3
5763.72
10D
5739.75
5696.62
20D
5499.33
5589.96
50D
5455.94
5571.76
100D
5877.66
5633.69
Volume trend — traded volume by day
13 Nov0L
12 Nov0L
11 Nov0L
9 Nov0L
8 Nov0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Procter & Gamble Health
Pharmaceuticals
Add Stock
Add Another

Mutual Funds Invested in Procter & Gamble Health

Fund name
AUM
UTI MNC Fund
4.13%
DSP Healthcare Fund
2.57%
UTI Healthcare Fund
2.21%

Procter & Gamble Health Returns Calculator

Ex-date: 27 Aug 2026
Ex-date: 12 Feb 2026
Ex-date: 12 Feb 2026

Procter & Gamble Health Latest News

2 months ago
MCX, Honasa Consumer, Paras Defence, other upcoming dividend stocks, bonus issues in focus this week; check list
3 months ago
P&G Health Q1 FY27 earnings: Net profit surges 45%; revenue grows to ₹364 crore YoY
3 months ago
P&G Hygiene and Health Care Q1 Results: Net profit slips 34% to ₹126 crore, revenue falls 5%
3 months ago
P&G Hygiene and Health Care Q3 results: Net profit up 12% YoY; firm announces one time special interim dividend
5 months ago
Procter & Gamble Health shares rally 19% after strong earnings; check all Q4 numbers
5 months ago
P&G Health Q4 results: Net profit jumps 56% YoY; board recommends dividend of ₹45 per share for FY26
Showing news item 1 of 6

Top Gainers

POWERINDIA Share Price
₹31595.00
+3050 (+10.68%)
AMBER Share Price
₹6772.00
+563 (+9.07%)
ANURAS Share Price
₹1300.60
+98.8 (+8.22%)
ITI Share Price
₹268.07
+17.06 (+6.8%)
ACI Share Price
₹455.05
+28.35 (+6.64%)
See more

Top Losers

ASTRAZEN Share Price
₹6031.50
-407 (-6.32%)
MAHSEAMLES Share Price
₹540.90
-29.7 (-5.21%)
FDC Share Price
₹371.45
-18.95 (-4.85%)
MANYAVAR Share Price
₹473.85
-23.3 (-4.69%)
NETWORK18 Share Price
₹26.95
-1.3 (-4.6%)
See more

Procter & Gamble Health Share Price FAQs

Please be aware that Procter & Gamble Health stock prices are subject to continuous fluctuations due to various factors.